NCT07043218View on ClinicalTrials.gov

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 10, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
B-cell Acute Lymphoblastic Leukemia
Interventions
DRUG

Chimeric Antigen Receptor T Cells (CAR-T)

chimeric antigen receptor T cells

Trial Locations (1)

200065

Shanghai Tongji Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Tongji Hospital, Tongji University School of Medicine

OTHER